Spectral karyotyping identifies new rearrangements, translocations, and clinical associations in diffuse large B-cell lymphoma

Blood

Volumn 99, Issue 7, 2002, Pages 2554-2561

  Nanjangud, Gouri ^a,b   Rao, Pulivarthi H ^a,b   Hegde, Abhijith ^a,b   Teruya Feldstein, Julie ^a,b   Donnelly, Gerard ^a,b   Qin, Jing ^a,b   Jhanwar, Suresh C ^a,b   Zelenetz, Andrew D ^a,b   Chaganti, R S K ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CHROMOSOME ABERRATION; CHROMOSOME BANDING PATTERN; CHROMOSOME BREAKAGE; CHROMOSOME LOSS; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 7; CLINICAL ARTICLE; CYTOGENETICS; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; KARYOTYPING; MALE; MOLECULAR STABILITY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS;

EID: 0036529830     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.7.2554     Document Type: Article

References (36)

1. Recurring chromosomal abnormalities in non-Hodgkin's lymphoma: Biologic and clinical significance
2. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
3. Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas
4. Cytogenetic analysis of 363 consecutively ascertained diffuse large B-cell lymphomas
5. Multicolor spectral karyotyping of human chromosomes
6. Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myeloma
7. Identification of new nonrandom translocations in multiple myeloma with multicolor spectral karyotyping
8. Spectral karyotype analysis of T-cell acute leukemia
9. Comparison of spectral karyotyping and conventional cytogenetics in 39 patients with acute myeloid leukemia and myelodysplastic syndrome
10. Acute leukemia cytogenetics: An evaluation of combining G-band karyotyping with multi-color spectral karyotyping
11. Reassessment of childhood B-lineage lymphoblastic leukemia karyotypes using spectral analysis
12. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: Correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment
13. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma clinical correlations
14. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997
15. Deregulation of FCGR2B expresion by 1q21 rearrangements in follicular lymphomas
16. A predictive model for aggressive non-Hodgkin's lymphoma
17. There are differences in cytogenetic abnormalities among histologic subtypes of the non-Hodgkin's lymphomas
18. Cytogenetic analysis of 147 cases of non-Hodgkin's lymphoma: Non-random chromosomal abnormalities and his tological correlations
19. Chromosomal abnormalities in untreated patients with non-Hodgkin's lymphoma: Associations with histology, clinical characteristics, and treatment outcome
20. Cytogenetic evolution patterns in non-Hodgkin's lymphoma
21. Chromosomal and gene amplification in diffuse large B-cell lymphoma
22. DNA copy number changes in diffuse large B-cell lymphoma-comparative genomic hybridization study
23. BCL2 overexpression associated with chromosomal amplification in diffuse large B-can lyrmphoma
24. Similar patterns of genomic alterations characterize primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma
25. The clinical relevance of t(14; 18)/BCL-2 rearrangement and DEL 6q in diffuse large cell lymphoma and immunoblastic lymphoma
26. Pathologic prognostic factors in diffuse aggressive non-Hodgkin's lymphoma
27. LAZ3 rearrangements in non-Hodgkin's lymphoma: Correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients
28. Clinical significance of bcl-2-MBR gene rearrangement and protein expression in diffuse large-cell non-Hodgkin's lymphoma: An analysis of 83 cases
29. Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma
30. Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: Clinical relevance in 71 patients
31. Cytogenetic abnormalities predict clinical outcome in non-Hodgkin lymphoma
32. bcl-2 and other genomic alterations in the prognosis of large-cell lymphoma
33. Refractoriness to chemotherapy and poor survival related to abnormalities of chromosomes 17 and 7 in lymphoma
34. Clinicopathogenetic significance of chromosomal abnormalities in patients with blastic peripheral B-cell lymphoma
35. Sequential analysis of 43 patients with nonHodgkin's lymphoma: Clinical correlations with cytogenetic, histologic, immunophenotyping, and molecular studies